A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer

Khanh Do, Liang Cao, Zhigang Kang, Baris Turkbey, Maria L. Lindenberg, Erin Larkins, Beata Holkova, Seth M. Steinberg, Mark Raffeld, Cody J. Peer, William D. Figg, Michelle Eugeni, Paula Jacobs, Peter Choyke, John J. Wright, James H. Doroshow, Shivaani Kummar

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences